Nathan Robbins

1.1k total citations
34 papers, 778 citations indexed

About

Nathan Robbins is a scholar working on Cardiology and Cardiovascular Medicine, Sensory Systems and Molecular Biology. According to data from OpenAlex, Nathan Robbins has authored 34 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 9 papers in Sensory Systems and 8 papers in Molecular Biology. Recurrent topics in Nathan Robbins's work include Ion Channels and Receptors (9 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Ion channel regulation and function (4 papers). Nathan Robbins is often cited by papers focused on Ion Channels and Receptors (9 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Ion channel regulation and function (4 papers). Nathan Robbins collaborates with scholars based in United States, Greece and Canada. Nathan Robbins's co-authors include Jack Rubinstein, Sheryl E. Koch, Michael Tranter, Min Jiang, Andra L. Blomkalns, John N. Lorenz, W. Keith Jones, Evangelia G. Kranias, Xiaoping Ren and Wenfeng Cai and has published in prestigious journals such as PLoS ONE, Circulation Research and CHEST Journal.

In The Last Decade

Nathan Robbins

34 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan Robbins United States 16 274 229 181 112 110 34 778
Elaine Hillas United States 13 286 1.0× 542 2.4× 55 0.3× 116 1.0× 115 1.0× 21 961
Gerald Wölkart Austria 18 258 0.9× 322 1.4× 58 0.3× 126 1.1× 383 3.5× 40 961
Hitesh Soni United States 15 244 0.9× 65 0.3× 63 0.3× 64 0.6× 56 0.5× 35 538
Shefalee K. Bhavsar Germany 19 513 1.9× 89 0.4× 40 0.2× 90 0.8× 283 2.6× 32 883
Xin Qin China 14 323 1.2× 41 0.2× 61 0.3× 126 1.1× 68 0.6× 37 826
Xinling Du China 15 271 1.0× 325 1.4× 47 0.3× 142 1.3× 41 0.4× 58 775
Su‐Juan Kuang China 17 435 1.6× 332 1.4× 17 0.1× 51 0.5× 87 0.8× 56 865
Xuexue Zhu China 14 315 1.1× 76 0.3× 14 0.1× 99 0.9× 62 0.6× 39 667

Countries citing papers authored by Nathan Robbins

Since Specialization
Citations

This map shows the geographic impact of Nathan Robbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Robbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Robbins more than expected).

Fields of papers citing papers by Nathan Robbins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Robbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Robbins. The network helps show where Nathan Robbins may publish in the future.

Co-authorship network of co-authors of Nathan Robbins

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Robbins. A scholar is included among the top collaborators of Nathan Robbins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Robbins. Nathan Robbins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shaw, Pallab, et al.. (2025). Anoikis resistance in Cancer: Mechanisms, therapeutic strategies, potential targets, and models for enhanced understanding. Cancer Letters. 624. 217750–217750. 1 indexed citations
2.
Gupta, Nishant, Bin Zhang, Yuan Zhou, et al.. (2023). Safety and Efficacy of Combined Resveratrol and Sirolimus in Lymphangioleiomyomatosis. CHEST Journal. 163(5). 1144–1155. 16 indexed citations
3.
Rubinstein, Jack, Nathan Robbins, Karen K. Evans, et al.. (2022). Repurposing Probenecid for the Treatment of Heart Failure (Re-Prosper-HF): a study protocol for a randomized placebo-controlled clinical trial. Trials. 23(1). 266–266. 3 indexed citations
4.
Grafton, Kate, et al.. (2022). Association of Chartered Physiotherapists in Respiratory Care scoping review: Post-operative physiotherapy management in upper gastrointestinal (GI) surgery. Leeds Beckett Repository (Leeds Beckett University). 54(2). 92–106. 4 indexed citations
5.
Koch, Sheryl E., et al.. (2021). Pharmacologic Inhibition of Pain Response to Incomplete Vascular Occlusion Blunts Cardiovascular Preconditioning Response. Cardiovascular Toxicology. 21(11). 889–900. 2 indexed citations
6.
McDermott, Michael, et al.. (2020). Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy. PLoS ONE. 15(3). e0230386–e0230386. 12 indexed citations
7.
O’Connor, Brian P., Nathan Robbins, Sheryl E. Koch, & Jack Rubinstein. (2020). TRPV2 channel-based therapies in the cardiovascular field. Molecular underpinnings of clinically relevant therapies. Progress in Biophysics and Molecular Biology. 159. 118–125. 11 indexed citations
8.
Anthony, Sarah, Michelle L. Nieman, Xiaoqing Wu, et al.. (2019). Human antigen R as a therapeutic target in pathological cardiac hypertrophy. JCI Insight. 4(4). 47 indexed citations
9.
Gardner, George, Joshua G. Travers, Qian Jiang, et al.. (2019). Phosphorylation of Hsp20 Promotes Fibrotic Remodeling and Heart Failure. JACC Basic to Translational Science. 4(2). 188–199. 15 indexed citations
10.
11.
Koch, Sheryl E., Shannon Jones, Nathan Robbins, et al.. (2016). Transient receptor potential vanilloid 2 function regulates cardiac hypertrophy via stretch-induced activation. Journal of Hypertension. 35(3). 602–611. 27 indexed citations
12.
Jones, Shannon, David E. Hall, Min Jiang, et al.. (2016). The role of transient receptor potential vanilloid 2 channel in cardiac aging. Aging Clinical and Experimental Research. 29(5). 863–873. 13 indexed citations
13.
Robbins, Nathan, et al.. (2014). Isolation and Excision of Murine Aorta; A Versatile Technique in the Study of Cardiovascular Disease. Journal of Visualized Experiments. e52172–e52172. 11 indexed citations
14.
Koch, Sheryl E., Kevin J. Haworth, Nathan Robbins, et al.. (2013). Age- and Gender-Related Changes in Ventricular Performance in Wild-Type FVB/N Mice as Evaluated by Conventional and Vector Velocity Echocardiography Imaging: A Retrospective Study. Ultrasound in Medicine & Biology. 39(11). 2034–2043. 21 indexed citations
15.
Basford, Joshua E., Sheryl E. Koch, Vivek Singh, et al.. (2013). Smooth Muscle LDL Receptor-Related Protein-1 Deletion Induces Aortic Insufficiency and Promotes Vascular Cardiomyopathy in Mice. PLoS ONE. 8(11). e82026–e82026. 14 indexed citations
16.
Robbins, Nathan, Sheryl E. Koch, & Jack Rubinstein. (2013). Targeting TRPV1 and TRPV2 for potential therapeutic interventions in cardiovascular disease. Translational research. 161(6). 469–476. 41 indexed citations
17.
Rubinstein, Jack, Valerie M. Lasko, Sheryl E. Koch, et al.. (2013). Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance. American Journal of Physiology-Heart and Circulatory Physiology. 306(4). H574–H584. 56 indexed citations
18.
Koch, Sheryl E., Xiaoqian Gao, Lauren Haar, et al.. (2012). Probenecid: Novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation. Journal of Molecular and Cellular Cardiology. 53(1). 134–144. 73 indexed citations
19.
Robbins, Nathan, Sheryl E. Koch, Michael Tranter, & Jack Rubinstein. (2011). The History and Future of Probenecid. Cardiovascular Toxicology. 12(1). 1–9. 118 indexed citations
20.
Robbins, Nathan, et al.. (1978). Hemolytic anemia. Associated with severe Mycoplasma pneumoniae pneumonia.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 78(14). 2231–2. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elaine Hillas Breakdown of academic impact, for papers by Gerald Wölkart Breakdown of academic impact, for papers by Hitesh Soni Breakdown of academic impact, for papers by Shefalee K. Bhavsar Breakdown of academic impact, for papers by Xin Qin Breakdown of academic impact, for papers by Xinling Du Breakdown of academic impact, for papers by Su‐Juan Kuang Breakdown of academic impact, for papers by Xuexue Zhu
Rankless by CCL
2026